Speciality: Rheumatology
Description:
A warm welcome to all the medical professionals in this interesting session on the role of tofacitinib in managing rheumatoid arthritis.
Immunological pathways play a crucial role in disease management, especially in the case of rheumatological disease. Managing rheumatoid arthritis often becomes difficult due to its rate of progression and associated health issues.
The webinar will help in gaining important insights on JAK-inhibiting drugs like tofacitinib in controlling rheumatoid arthritis. It is a competitive inhibitor of JAK that binds to adenosine triphosphate in the kinase domain.
Tofacitinib inhibits the process of intracellular signaling from the receptor to the cellular nucleus and inhibits the inflammation process via inhibition of the Janus kinases, which eventually help in controlling rheumatoid arthritis.
Therefore, listen to the webinar, grab the knowledge that is shared and follow HiDoc for more such interesting webinar sessions.
See More Webinars @ Hidoc Webinars
1.
Researchers can now forecast how prostate cancer bone metastases will react to radium-223 treatment.
2.
Cardiopulmonary fitness is key for helping breast cancer patients manage post-diagnosis symptoms, say researchers
3.
In R/R Follicular Lymphoma, Tisa-Cel Produces Long-Lasting Responses.
4.
In MDS at Lower Risk, Novel Therapy Diminished Transfusion Dependency.
5.
WHO launches plan for free child cancer medicines
1.
Innovative Directions in Hematology Across Clinical Settings
2.
Transformative Approaches in Hematology for Healthcare Excellence
3.
How HLH is Revolutionizing Healthcare
4.
Essential Perspectives in Hematology and Patient Outcomes
5.
Neutrophil Profiling and AI Rewrites Cancer Diagnosis
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session
2.
Navigating the Complexities of Ph Negative ALL - Part III
3.
Role of Nimotuzumab in Management of Nasopharyngeal Cancer
4.
Navigating the Complexities of Ph Negative ALL - Part X
5.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation